Mental Health First 16 Nov 2022

Mental Health First

Awareness that mental health is as vital as physical health has grown increasingly prevalent in recent years. Traditionally not a huge consideration in clinical trials, signs are showing of late that the research industry is growing increasingly aware of its importance. Measures are now being embraced more often that take the mental burden of trial participation into consideration, as well as the physical.

While in many cases, relief at being able to participate in a trial, receiving a drug for a difficult condition and/or a feeling of wellbeing at contributing to the greater good can improve the mental health of a participant, in others, stress and anxiety may be heightened. Patients may be fearful that the trial drug won’t be effective, or that it may cause adverse effects or, indeed, be a placebo. Financial and practical concerns too can lead to anxiety and depression.

So what can be done to improve the patient experience? Here are three ideas which can help improve the patient experience:

  • Monitoring Mental Health Feedback
Adding questions about emotional wellbeing into electronic patient diaries allows doctors to follow up with patients who might need additional support and paints a more holistic picture of the effects of trial participation.

  • Access to Support
Onboarding materials provided to patients can also direct them toward resources which support mental health — one-on-one counselling and mental health practitioners, for example, who can be accessed either during or subsequent to the trial period — mental health issues can, after all, arise at any time.

  • More Inclusive Protocols
Trial criteria which excludes people with psychiatric problems from enrolling is another area which could be examined to widen the participant pool. For example, figures in the US show that 1 in 5 adults experience a mental health problem which renders a sizeable portion of the population ineligible to take part in trials. Re-examination of trial protocols to make them more specific and detailed, could enable more and more of these people to participate.

Such additional care will yield benefits for the industry as a whole. Making trials kinder will certainly decrease drop-out rates and will also increase diversification of subjects. It stands to reason that caring for mental health will improve the overall patient experience, leading to better results for all.
Back to the list


COREX Logistics is a supply and logistics company with headquarters in Ireland, working with pharma and patients to facilitate improved healthcare worldwide.

Our expert international team works across an 80-country network, specialising in the EMEA region, providing the latest in clinical trial logistics technology and systems, cold-chain delivery, temperature-controlled transportation and storage services. From sourcing, procurement and customs clearance, to labelling, returns and destruction, we cover every link in the supply chain. We also run an established Named Patient Programme and provide Patient-Oriented services. With extensive knowledge and on-the-ground insight into our markets, we create innovative solutions with the ultimate goal of improving the lives of patients.

To learn more about our range of expert services, contact us today on

If you found this article helpful, consider sharing it with others who might also benefit from it. Sharing knowledge is a wonderful thing to do and can be very helpful to others.


We’re here to help.
Email us at or use our feedback form to send us your question.

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.